132
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Phosphodiesterase type 5 inhibitors (PDE5-Is) are currently the first-line therapy for erectile dysfunction (ED), but available studies investigating the comparative effects of different PDE5-Is are limited.

          Related collections

          Author and article information

          Journal
          Eur. Urol.
          European urology
          1873-7560
          0302-2838
          May 2013
          : 63
          : 5
          Affiliations
          [1 ] Division of Epidemiology, School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong.
          Article
          S0302-2838(13)00024-9
          10.1016/j.eururo.2013.01.012
          23395275
          03f35402-6329-4ecb-8c96-032a0a0d2dd3
          Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.
          History

          Comments

          Comment on this article